4//SEC Filing
Henderson Jane 4
Accession 0000950170-25-107545
CIK 0001744659other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 8:32 PM ET
Size
7.9 KB
Accession
0000950170-25-107545
Insider Transaction Report
Form 4
Henderson Jane
Director
Transactions
- Exercise/Conversion
Common Stock
2025-08-12$7.01/sh+3,000$21,027→ 12,398 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-12−3,000→ 11,797 totalExercise: $7.01Exp: 2029-04-02→ Common Stock (3,000 underlying) - Sale
Common Stock
2025-08-12$47.46/sh−3,000$142,371→ 9,398 total
Footnotes (1)
- [F1]The options are vested and currently exercisable.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001422304
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 8:32 PM ET
- Size
- 7.9 KB